From Single Disease to Complete Patient Management
21 July 2015 | IAS-Industry Consultation on the Integration of HIV and Other Diseases, Vancouver, Canada (By invitation only)
The increasing importance to strengthen health systems with integrated and coordinated approaches for HIV and other diseases is at the forefront of new objectives. Primary focus has been set upon the existing, but often “silent” tuberculosis (TB) integration, hepatitis C virus (HCV), and the emerging recognition of the increased burden in low and middle-income countries of non-communicable diseases (NCDs). These diseases often greatly affect PLHIV and their communities. Lessons learned from the HIV response are critical in reaching integration and strengthening of health systems in a sustainable manner. However, integration approaches must carefully assess the risks and benefits to existing structures, and consider all of the relevant stakeholders in implementation.
The International AIDS Society (IAS)-Industry Consultation Series allows for strategic, high-level discussions between the IAS (Staff and Governing Council) and industry; this is an invaluable opportunity for industry, the IAS, and the global response to HIV. For IAS 2015, the IAS’s Industry Liaison Forum (ILF) has chosen to focus the IAS-Industry Consultation on the topic of integration of responses for HIV and other diseases (in particular TB, HCV and NCDs).
This IAS-Industry Consultation on the Integration of HIV and Other Diseases: From Single Disease to Complete Patient Management provided a platform for participants to meet and discuss the challenges and opportunities to “bridge the gap” of integrated approaches, and health system strengthening between HIV and TB/HCV/NCDs. A keynote presentation set the stage and frame health system strengthening and integration from a HIV perspective, while an open, roundtable discussion allowed all participants to contribute to the exchange of ideas. The discussion covered issues around (1) Ongoing integration of HIV and TB: Is it working? (2) Upcoming integration of HIV and HCV: Are systems strong enough to cater for this integration? (3) Foreseen integration of HIV and NCDs: Will low and middle-income countries be ready? This included considerations on the impact of the flow of financing on product research and development and the overall integration of the response to multiple diseases.
- Related documents
Kenneth Mayer, Fenway Institute, United States – ILF Co-Chair and Manuel Gonçalves, ViiV Healthcare, United Kingdom – ILF Co-Chair
Presentation I: Health system strengthening and integration – The rationale
Deborah Birx, PEPFAR, United States
Presentation II: Health system strengthening and integration – The Brazilian perspective
Fábio Mesquita, Department of STDs, AIDS and Viral Hepatitis, Brazil
Roundtable discussion: Challenges and opportunities for integration of other diseases into the HIV response
Facilitator: Catherine Hankins, Amsterdam Institute for Global Health and Development, The Netherlands - ILF Advisory Group member
- Ongoing integration: HIV and TB - Is it working?
Primary discussant: Alex Muganga Muganzi (Infectious Diseases Institute Makerere University College of Health Sciences, Uganda) – GC Member
- Upcoming integration: HIV and viral hepatitis - Are systems strong enough to cater for this integration?
Primary discussant: Mauro Schechter (Universidade Federal do Rio de Janeiro, Brazil) - ILF Advisory Group member
- Foreseen integration: HIV and non-communicable diseases - Will low and middle-income countries be ready?
Short introduction on NCDs - “ Appendix NCDs ”
Primary discussant: Stefano Vella (Istituto Superiore di Sanità, Italy) – ILF Advisory Group member
Summary and closing
Kenneth Mayer, Fenway Institute, United States – ILF Co-Chair, Manuel Gonçalves, ViiV Healthcare, United Kingdom – ILF Co-Chair and Sébastien Morin, International AIDS Society, Switzerland – ILF Research Officer